Strength
25 mg/1
Manufacturer
Pfizer Inc.NDC
00069077038
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
1/1/2024
Active Ingredients
SUNITINIB MALATEApproval Type
New Drug (NDA)
FDA Application
NDA021938On Market Since
1/26/2006
Pharmacological Classes
Kinase Inhibitor
Protein Kinase Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
ZORTRESS 0.5 MG TABLET
Brand
00078041420•Novartis Pharmaceuticals Corporation
$17.8041
per EA
ZORTRESS 0.75 MG TABLET
Brand
00078041520•Novartis Pharmaceuticals Corporation
$27.0419
per EA
OPZELURA 1.5% CREAM
Brand
50881000705•Incyte Corporation
$34.1433
per GM
XELJANZ 5 MG TABLET
Brand
00069100101•Pfizer Inc.
$73.8329
per EA
GLEEVEC 100 MG TABLET
Brand
00078040134•Novartis Pharmaceuticals Corporation
$90.8197
per EA
OLUMIANT 2 MG TABLET
Brand
00002418230•Eli Lilly and Company
$92.2936
per EA
TASIGNA 200 MG CAPSULE
Brand
00078052651•Novartis Pharmaceuticals Corporation
$94.1452
per EA
TASIGNA 200 MG CAPSULE
Brand
00078052687•Novartis Pharmaceuticals Corporation
$94.1452
per EA
XELJANZ 10 MG TABLET
Brand
00069100201•Pfizer Inc.
$103.5456
per EA
RHOPRESSA 0.02% OPHTH SOLUTION
Brand
70727049725•Alcon Laboratories, Inc.
$131.9200
per ML